Answers are grounded in this paper and cite their sources.
Plain Language SummaryWhat is this summary about?Fabry disease is a rare genetic condition where an enzyme, which would normally be present in cells to recycle fatty substances, does not work properly. Fatty substances build up in the lysosome (the cell’s recycling unit), and vital organs become damaged throughout the body.Clinical trials have shown that a treatment called migalastat is effective for treating Fabry disease; however, data on long-term migalastat treatment in real-life usual care are needed. To understand if migalastat treatment in usual care produced similar results to those in clinical trials, researchers looked at 125 people with Fabry disease who received migalastat in usual care for an average of 3.9 years.The researchers used information from the followME Fabry Pathfinders registry, including kidney function, frequency of Fabry-associated complications, and serious health complications. This summary is about the findings from these 125 people.What is the registry looking at?The registry is looking at the health and wellbeing of people with Fabry disease over time who are taking currently available Fabry disease treatments in real-life usual care, focusing on migalastat.What were the results?During migalastat treatment, the rate of kidney function decline in people with Fabry disease was similar to the age-related decline in unaffected people. Most people did not have any specific Fabry-associated complications or any serious health issues during migalastat treatment.What do the results mean?Based on data from real-life usual care, the results of this analysis suggest that migalastat may be an effective long-term treatment for people with Fabry disease who have changes in the Fabry disease gene that are suitable (amenable) to migalastat treatment.How to say (download PDF and double click sound icon to play sound)…Enzyme: EN-zimeGlomerular: glom-AIR-yool-areMigalastat: mi-GAL-a-statPhenotype: FEE-noh-typeThis is an abstract of the Plain Language Summary of Publication article.
No takes yet. Share an insight, caveat, or question.
Hughes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: